WHO Supports DRC with Ebola Outbreak and Continues Investigation of Unexplained Acute Hepatitis Cases in US and Europe 27/04/2022 Raisa Santos The World Health Organization has announced an outbreak of Ebola in the Democratic Republic of Congo and its continued investigation of almost 200 cases of unexplained acute hepatitis in the US and Europe in a media briefing Tuesday afternoon. Two cases of Ebola have been confirmed in the northwestern Democratic Republic of Congo, prompting health […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
How Virtual Healthcare Services are Coming to the Aid of Ukraine 01/04/2022 Irene Velicer via Geneva Solutions The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> Posts navigation Older postsNewer posts